Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CLOT-LESS - CLOsure Tailored: LEss Antithrombotic Strategy After LAAC for Stroke Prevention

NCT07575867 is registered in ClinicalTrials.gov with National Medical Research Center for Therapy and Preventive Medicine as lead sponsor.

NCT NCT07575867
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07575867 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CLOT-LESS - CLOsure Tailored: LEss Antithrombotic Strategy After LAAC for Stroke Prevention
Lead sponsor
National Medical Research Center for Therapy and Preventive Medicine
Phase
Observational
Overall status
Recruiting
Start date
April 30, 2026
Completion date
April 30, 2032
Enrollment
464 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anticoagulants / administration & dosage, atrial fibrillation, hemorrhage, left atrial appendage closure, reduced-dose apixaban, stroke prevention in patients with atrial fibrillation, thromboembolism